The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
Related Posts
Claude’s consumer growth surge continues after Pentagon deal debacle
Claude’s app is now seeing more new installs than ChatGPT and is growing its daily active users.
Google faces another AI training lawsuit from major publishers
Hachette, Cengage, Elsevier, and other publishers allege that Google trained its AI on copyrighted works without the necessary…
Only 16 percent of Americans think AI will have a positive impact on society, a new study shows
Although Wall Street loves AI, every day Americans are significantly less optimistic about the industry, a new report…
